Portal Hypertension VI: Proceedings of the Sixth Baveno Consensus Workshop: Stratifying Risk and Individualizing Care

Front Matter....Pages i-xxi
Front Matter....Pages 1-1
Introduction: Baveno I to Baveno VI.... and Beyond....Pages 3-7
The Concept of Risk Stratification....Pages 9-18
Competing Risks and Prognostic Stages in Cirrhosis....Pages 19-28
Front Matter....Pages 29-29
Results of the Questionnaire....Pages 31-37
Identifying Compensated Advanced Chronic Liver Disease: When (Not) to Start Screening for Varices and Clinically Significant Portal Hypertension....Pages 39-49
How to Screen?....Pages 51-62
When and How to Perform Surveillance....Pages 63-72
Cost Considerations....Pages 73-76
Consensus Statements: Session 1—Screening and Surveillance....Pages 77-80
Front Matter....Pages 81-81
(Pre)Primary Prophylaxis: Where Were We and Where Are We Heading?....Pages 83-87
Defining Clinical Hints to Predict Decompensation and Altering Paradigm in Patients with Cirrhosis....Pages 89-97
Antiviral Treatments and Residual Risk of Hepatic Decompensation....Pages 99-104
Etiological Treatments: Lifestyle Management....Pages 105-110
Liver Fibrosis: What Is Reversible and What Not? How to Assess Regression?....Pages 111-115
Potential Antifibrotic Therapies: Approaching the Bedside: Proof-of-Concept Studies (Part 1)....Pages 117-126
New Targets in Therapy: Statins, Antioxidants and Antiangiogenic Strategies....Pages 127-133
Consensus Statements: Session 2—Impact of Etiological and Anti-fibrotic Therapy....Pages 135-136
Front Matter....Pages 137-137
The Gut Microbiome and Cirrhosis: Basic Aspects....Pages 139-168
The Gut Microbiome and Cirrhosis: Clinical Aspects....Pages 169-184
Front Matter....Pages 185-185
Result of the Questionnaire....Pages 187-194
Front Matter....Pages 185-185
Introduction: Prevention of Decompensation Versus Prevention of First Bleeding....Pages 195-204
Role of Comorbidities in the General Management of Compensated Cirrhosis, Including Malnutrition....Pages 205-214
Primary Prophylaxis of First Variceal Bleeding....Pages 215-224
Endoscopic Band Ligation in Primary Prophylaxis....Pages 225-234
Consensus Statements: Changing Scenarios: Prevention of Decompensation....Pages 235-238
Front Matter....Pages 239-239
Management of Acute Variceal Bleeding in Patients with Cirrhosis: General Management, Drug Therapy, and Endoscopic Treatment....Pages 241-259
A la Carte Treatment of Acute Variceal Bleeding....Pages 261-279
Consensus Statements: Management of the Acute Bleeding Episode....Pages 281-285
Front Matter....Pages 287-287
Portal Hypertension in Pediatrics: Controversies and Challenges 2015 Report....Pages 289-300
Front Matter....Pages 301-301
Introduction and Survey Results....Pages 303-309
Prevention of Variceal Rebleeding: Stratifying Risk and Individualizing Care....Pages 311-316
Secondary Prophylaxis in Special Patient Populations....Pages 317-332
Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis....Pages 333-339
Impact of Treatment of Non-bleeding Complications of Cirrhosis on the Risk of Variceal Bleeding....Pages 341-353
Issues in Trial Design and Areas Needing Further Research....Pages 355-363
Consensus Statements: Preventing Recurrent Variceal Hemorrhage and Other Decompensating Events....Pages 365-367
Front Matter....Pages 369-369
Results of the Questionnaire....Pages 371-376
Extrahepatic Portal Vein Obstruction (EHPVO) and Idiopathic Portal Hypertension: East Versus West....Pages 377-395
Budd-Chiari Syndrome/Hepatic Venous Outflow Tract Obstruction: East vs West....Pages 397-410
Antithrombotic Treatment in Cirrhosis....Pages 411-420
Front Matter....Pages 369-369
Session 6: Consensus Statements – Vascular Diseases of the Liver in Cirrhotic and Noncirrhotic Portal Hypertension....Pages 421-426